Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ellen L. Jones, MD, PhD
Duke Cancer Institute
Principal Investigator - Leonard R. Prosnitz, MD
Duke Cancer Institute
Principal Investigator - Mark Dewhirst, DVM PhD
Duke Cancer Institute
Principal Investigator - Zeljko Vujaskovic, MD PhD
Duke Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Duke Cancer Institute
Durham, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2003
- Primary completion
- 30 Nov 2008
- Completion
- 30 Jun 2009
- Last update posted
- 17 Sept 2013
- Registered enrollment
- 101
- Registry id
- NCT00085631
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.